SOTIO is a biotechnology company developing a new immunotherapy based on activated dendritic cells for the treatment of cancer.
Sotio Biotech has raised €280M across 1 funding round from 1 investor, most recently a round in Dec 2021. Based in Prague, Czech Republic; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2021-12-02 | Other | €280M |
| PPF Group |
| View deal → |
